Rockefeller Capital Management’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.98K Buy
20
+8
+67% +$964 ﹤0.01% 4564
2026
Q2
$1.6K Sell
12
-38
-76% -$4.3K ﹤0.01% 4464
2026
Q1
$5.57K Sell
50
-1
-2% -$118 ﹤0.01% 4208
2025
Q4
$6.88K Buy
+51
New +$5.56K ﹤0.01% 3955

Other funds holding ABVX

Rockefeller Capital Management's ABVX Position: Q3 2026 in Review

Rockefeller Capital Management increased its Abivax (ABVX) stake by 67% in Q3 2026, buying an estimated $964 and bringing the position to 20 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4564.

Rockefeller Capital Management first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.88K in Q4 2025. 317 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Rockefeller Capital Management held 20 shares of Abivax worth $1.98K as of Q3 2026.
  • Rockefeller Capital Management bought 8 Abivax shares in Q3 2026, an estimated $964.
  • Abivax made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4564 holding.
  • Rockefeller Capital Management first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Abivax position peaked at $6.88K in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.